🔗 Share this article

This year's prestigious award in medical science was awarded for transformative discoveries that clarify how the immune system targets harmful infections while sparing the healthy tissues.

A trio of renowned researchers—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this accolade.

The work uncovered specialized "sentinels" within the defense system that remove malfunctioning defense cells capable of harming the body.

These discoveries are now enabling new therapies for immune disorders and malignancies.

These laureates will divide a prize fund valued at 11 million SEK.

Decisive Discoveries

"Their research has been decisive for comprehending how the body's defenses functions and the reason we don't all suffer from serious self-attack conditions," commented the chair of the Nobel Committee.

This team's research explain a fundamental question: How does the immune system protect us from countless infections while leaving our healthy cells intact?

The immune system uses immune cells that scan for signs of infection, including viruses and germs it has not met before.

Such cells utilize detectors—known as recognition units—that are generated by chance in a vast number of variations.

That gives the defense network the ability to combat a broad range of threats, but the unpredictability of the mechanism unavoidably creates white blood cells that may target the host.

Protectors of the Immune System

Researchers earlier understood that a portion of these harmful defense cells were destroyed in the thymus—the site where white blood cells develop.

This year's award recognizes the discovery of T-reg cells—known as the body's "security guards"—which patrol the system to disarm any immune cells that assault the body's own tissues.

It is known that this mechanism fails in self-attack conditions such as type-1 diabetes, multiple sclerosis, and RA.

A prize committee added, "The findings have established a new field of investigation and spurred the creation of new therapies, for instance for cancer and immune disorders."

In malignancies, regulatory T-cells prevent the system from fighting the tumor, so studies are focused on reducing their numbers.

For self-attack disorders, trials are testing boosting T-reg cells so the organism is not under attack. A comparable method could also be useful in reducing the risks of organ transplant failure.

Pioneering Studies

Prof Sakaguchi, of a Japanese institution, performed tests on mice that had their thymus removed, causing autoimmune disease.

The researcher demonstrated that injecting defense cells from healthy animals could prevent the disease—suggesting there was a mechanism for preventing immune cells from harming the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Fred Ramsdell, currently at a biotech firm in a California city, were investigating an inherited immune disorder in rodents and people that led to the identification of a gene vital for how regulatory T-cells operate.

"The pioneering research has revealed how the body's defenses is kept in check by T-reg cells, stopping it from mistakenly targeting the body's own tissues," said a prominent physiology specialist.

"The research is a striking illustration of how fundamental biological study can have broad implications for human health."